Literature DB >> 24799631

Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.

George R Thompson1, Nathaniel Albert2, Greg Hodge3, Machelle D Wilson4, Jane E Sykes5, Derek J Bays3, Carolina Firacative6, Wieland Meyer6, Dimitrios P Kontoyiannis7.   

Abstract

Compared to Cryptococcus neoformans, little is known about the virulence of the molecular types in Cryptococcus gattii. We compared in vitro virulence factor production and survival data using a Drosophila model of infection to further characterize the phenotypic features of different cryptococcal molecular types. Forty-nine different isolates were inoculated into wild-type flies and followed for survival. In vitro, isolates were assessed for growth at 30 and 37°C, melanin production, capsule size, resistance to H(2)O(2), and antifungal susceptibility. A mediator model was used to assess molecular type and virulence characteristics as predictors of survival in the fly model. VGIII was the most virulent molecular type in flies (P < 0.001). At 30°C, VGIII isolates grew most rapidly; at 37°C, VNI isolates grew best. C. gattii capsules were larger than those of C. neoformans (P < 0.001). Mediator model analysis found a strong correlation of Drosophila survival with molecular type and with growth at 30°C. We found molecular-type-specific differences in C. gattii in growth at different temperatures, melanin production, capsule size, ability to resist hydrogen peroxide, and antifungal susceptibility, while growth at 30°C and the VGIII molecular type were strongly associated with virulence in a Drosophila model of infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24799631      PMCID: PMC4097627          DOI: 10.1128/IAI.01805-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans.

Authors:  E S Jacobson; G M Compton
Journal:  J Med Vet Mycol       Date:  1996 Jul-Aug

Review 2.  The Cryptococcus neoformans capsule: a sword and a shield.

Authors:  Teresa R O'Meara; J Andrew Alspaugh
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade.

Authors:  Read Pukkila-Worley; Quincy D Gerrald; Peter R Kraus; Marie-Josée Boily; Matthew J Davis; Steven S Giles; Gary M Cox; Joseph Heitman; J Andrew Alspaugh
Journal:  Eukaryot Cell       Date:  2005-01

4.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

Review 5.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

6.  Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence.

Authors:  Marcio L Rodrigues; Ernesto S Nakayasu; Debora L Oliveira; Leonardo Nimrichter; Joshua D Nosanchuk; Igor C Almeida; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-11-26

7.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

8.  Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.

Authors:  Charles E Gast; Luiz R Basso; Igor Bruzual; Brian Wong
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

9.  A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.

Authors:  Edmond J Byrnes; Wenjun Li; Ping Ren; Yonathan Lewit; Kerstin Voelz; James A Fraser; Fred S Dietrich; Robin C May; Sudha Chaturvedi; Sudha Chatuverdi; Vishnu Chaturvedi; Vishnu Chatuverdi; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

10.  The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.

Authors:  Popchai Ngamskulrungroj; Yun Chang; Edward Sionov; Kyung J Kwon-Chung
Journal:  mBio       Date:  2012-05-08       Impact factor: 7.867

View more
  14 in total

1.  Does the Capsule Interfere with Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Cryptococcus neoformans and Cryptococcus gattii?

Authors:  Danilo Y Thomaz; Rafaella C Grenfell; Monica S M Vidal; Mauro C Giudice; Gilda M B Del Negro; Luiz Juliano; Gil Benard; João N de Almeida Júnior
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.

Authors:  Mai Lee Yang; John Uhrig; Kiem Vu; Anil Singapuri; Michael Dennis; Angie Gelli; George R Thompson
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

3.  Differential In Vitro Cytokine Induction by the Species of Cryptococcus gattii Complex.

Authors:  Patricia F Herkert; Jessica C Dos Santos; Ferry Hagen; Fatima Ribeiro-Dias; Flávio Queiroz-Telles; Mihai G Netea; Jacques F Meis; Leo A B Joosten
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  An analysis of the population of Cryptococcus neoformans strains isolated from animals in Poland, in the years 2015-2019.

Authors:  Magdalena Florek; Urszula Nawrot; Agnieszka Korzeniowska-Kowal; Katarzyna Włodarczyk; Anna Wzorek; Anna Woźniak-Biel; Magdalena Brzozowska; Józef Galli; Anna Bogucka; Jarosław Król
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

5.  Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex.

Authors:  Rodrigo Almeida-Paes; Luã Cardoso de Oliveira; Manoel Marques Evangelista Oliveira; Maria Clara Gutierrez-Galhardo; Joshua Daniel Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Biomed Res Int       Date:  2015-04-19       Impact factor: 3.411

6.  Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii.

Authors:  Carolina Firacative; Shuyao Duan; Wieland Meyer
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

7.  MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors.

Authors:  Carolina Firacative; Chandler C Roe; Richard Malik; Kennio Ferreira-Paim; Patricia Escandón; Jane E Sykes; Laura Rocío Castañón-Olivares; Cudberto Contreras-Peres; Blanca Samayoa; Tania C Sorrell; Elizabeth Castañeda; Shawn R Lockhart; David M Engelthaler; Wieland Meyer
Journal:  PLoS Negl Trop Dis       Date:  2016-08-05

8.  Species in the Cryptococcus gattii Complex Differ in Capsule and Cell Size following Growth under Capsule-Inducing Conditions.

Authors:  Kenya E Fernandes; Christine Dwyer; Leona T Campbell; Dee A Carter
Journal:  mSphere       Date:  2016-12-28       Impact factor: 4.389

9.  Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus.

Authors:  Ferry Hagen; H Thorsten Lumbsch; Valentina Arsic Arsenijevic; Hamid Badali; Sebastien Bertout; R Blake Billmyre; M Rosa Bragulat; F Javier Cabañes; Mauricio Carbia; Arunaloke Chakrabarti; Sudha Chaturvedi; Vishnu Chaturvedi; Min Chen; Anuradha Chowdhary; Maria-Francisca Colom; Oliver A Cornely; Pedro W Crous; Maria S Cuétara; Mara R Diaz; Ana Espinel-Ingroff; Hamed Fakhim; Rama Falk; Wenjie Fang; Patricia F Herkert; Consuelo Ferrer Rodríguez; James A Fraser; Josepa Gené; Josep Guarro; Alexander Idnurm; María-Teresa Illnait-Zaragozi; Ziauddin Khan; Kantarawee Khayhan; Anna Kolecka; Cletus P Kurtzman; Katrien Lagrou; Wanqing Liao; Carlos Linares; Jacques F Meis; Kirsten Nielsen; Tinashe K Nyazika; Weihua Pan; Marina Pekmezovic; Itzhack Polacheck; Brunella Posteraro; Flavio de Queiroz Telles; Orazio Romeo; Manuel Sánchez; Ana Sampaio; Maurizio Sanguinetti; Pojana Sriburee; Takashi Sugita; Saad J Taj-Aldeen; Masako Takashima; John W Taylor; Bart Theelen; Rok Tomazin; Paul E Verweij; Retno Wahyuningsih; Ping Wang; Teun Boekhout
Journal:  mSphere       Date:  2017-08-30       Impact factor: 4.389

Review 10.  Ecoepidemiology of Cryptococcus gattii in Developing Countries.

Authors:  Patricia F Herkert; Ferry Hagen; Rosangela L Pinheiro; Marisol D Muro; Jacques F Meis; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.